Patents by Inventor James Keenan

James Keenan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240113974
    Abstract: Mobile management method, system and client. Method includes receiving a DNS query for a host name from an application on client; retrieving reputation data associated with host name from a local cache on client; and determining a policy based on host name and the reputation data. Based on determined policy for the host name, blocking attempted network flows to a host corresponding to host name to produce blocked attempted network flows. Method also includes sending attempted network flow metadata related to the blocked attempted network flows to a collector on client; transmitting the attempted network flow metadata from the collector to a VPN server pool via a VPN tunnel; and producing an anomaly report from the transmitted attempted network flow metadata. The anomaly report includes at least one of anomalies, cohorts, trends, location boundaries, detected network security issues, detected compromised clients and/or optimized network usage.
    Type: Application
    Filed: November 30, 2023
    Publication date: April 4, 2024
    Applicant: MOBILE SONIC, INC.
    Inventors: Joseph T. SAVARESE, Steven HECKT, Michael E. BRYANT, Eric C. MCNEILL, Carter SMITH, Elizabeth KIHSLINGER, Thomas Gunther HELMS, Camilla KEENAN-KOCH, Joseph G. SOUZA, Paul HOOVER, S. Aaron STAVENS, Christian E. HOFSTAEDTER, Jonathan SCOTT, Erik OLSON, James Scott SIMPKINS, Stephen Gregory FALLIN, John Harvey HILLOCK, Eivind NAESS, Michael Lee SNYDER, David Michael MIRLY, Marius LEE, Glenn Patrick ARANAS, Norman C. HAMER, Tridib DUTTA, Andrew James HOOVER, Thomas A. SWEET, Mark ANACKER, An PHAN
  • Patent number: 9770066
    Abstract: A footbed system (10) for footwear comprises an insole mechanism (14), a midsole mechanism (11), wherein the insole mechanism is positioned on the midsole mechanism, and the outsole mechanism (15) is positioned under the midsole mechanism. The insole mechanism comprises a footbed insole (1), a heel pad (2) and a forefoot pad (3). The footbed insole comprises a pad anatomically shaped to correspond to the sole of a human foot, wherein the heel pad is positioned in the hindfoot portion of the footbed insole, and the forefoot pad is positioned in the forefoot portion of the footbed insole. The outsole mechanism comprises an opening (15A) for exposing a natural gait line groove of the midsole mechanism.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: September 26, 2017
    Inventors: James Keenan Grelle, Willem J. L. Van Bakel
  • Publication number: 20160021972
    Abstract: A footbed system (10) for footwear comprises an insole mechanism (14), a midsole mechanism (11), wherein the insole mechanism is positioned on the midsole mechanism, and the outsole mechanism (15) is positioned under the midsole mechanism. The insole mechanism comprises a footbed insole (1), a heel pad (2) and a forefoot pad (3). The footbed insole comprises a pad anatomically shaped to correspond to the sole of a human foot, wherein the heel pad is positioned in the hindfoot portion of the footbed insole, and the forefoot pad is positioned in the forefoot portion of the footbed insole. The outsole mechanism comprises an opening (15A) for exposing a natural gait line groove of the midsole mechanism.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: James Keenan Grelle, Willem J.L. Van Bakel
  • Publication number: 20140148687
    Abstract: Method and medical devices for generating and stabilizing micro or nano bubbles, and systems and methods for therapeutic applications using the bubbles, is provided. Two novel bubble generating means are provided: in-line capillary tubes and mix chambers flow focusing, and cross flow bubble generation with optimized bubble detachment means. A method and medical device to stabilize bubble sizes and improve bubble size homogeneity through rectified diffusion is disclosed. A method and system to facilitate acoustic activation of therapeutic agents using ultrasound energy is provided.
    Type: Application
    Filed: February 4, 2014
    Publication date: May 29, 2014
    Applicant: Artenga Inc.
    Inventors: James A. Keenan, Junjie Gu, Philippe Joel Genereux, Adrian T. Bienkinsop, David H. Gerwing, Sebastien Roy Fournier, Sarah Katherine Dobbin
  • Patent number: 8679051
    Abstract: Method and medical devices for generating and stabilizing micro- or nano-bubbles, and systems and methods for therapeutic applications using the bubbles, are provided. The micro-bubbles may be used to enhance therapeutic benefits such as ultrasound-guided precision drug delivery and real-time verification, acoustic activation of large tumor masses, enhanced acoustic activation through longer retention of therapeutic agents at the point of interest, enhancement of high intensity focused ultrasound treatments, light activation of photodynamic drugs at a depth within a patient using extracorporeal light sources, probes, or sonoluminescence, and initiation of time reversal acoustics focused ultrasound to permit highly localized treatment.
    Type: Grant
    Filed: January 7, 2010
    Date of Patent: March 25, 2014
    Assignee: Artenga Inc
    Inventors: James A Keenan, Junjie Gu, Philippe Joel Genereux, Adrian T Bienkinsop, David H Gerwing, Sebastien Roy Fournier, Sarah Katherine Dobbin
  • Publication number: 20120296208
    Abstract: Medical apparatus and processes controllably generate medically useful micro or nano bubbles of medically desirable and controllably selectable size, size distribution, homogeneity and concentration (and/or other key bubble parameters) for patient infusion, and/or which may incorporate therapeutic or other agents for patient infusion and/or may be combined with therapeutic or other agents prior to infusion into patients. The bubble generation apparatus and processes controllably permit the adjustment and selection of key bubble parameters through bubble generation actuation and orientation techniques and through selection of bubble fluid compositions in order to facilitate medical research and/or to optimize treatment for imaging, therapy, sonoporation, inertial and non-inertial cavitation, and acoustic activation, among other medical uses. Disposable cartridges containing such bubbles are provided and may include means for patient infusion.
    Type: Application
    Filed: August 2, 2012
    Publication date: November 22, 2012
    Inventors: James A. Keenan, Adrian Blenkinsop, Phillipe Genereux
  • Patent number: 8291567
    Abstract: In one embodiment, the present invention provides a method for forming battery tray for holding cylindrical cell batteries. The method includes forming a battery try including a base support having a generally flat bottom surface and multiple adjacent cylindrical cavities are formed within the base support, using a circle packing algorithm to form the cylindrical cavities. The adjacent cavities each have at least some interstitial cylindrical riser wall structures formed with a predetermined height to hold the cylindrical cell batteries. In another embodiment, the present invention allows for packing maximum energy density per layer. This allows lifetime and power output of a battery powered device to be optimized and/or increased.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: October 23, 2012
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Timothy James Keenan, Joshua Bianchi
  • Patent number: 8257338
    Abstract: Medical apparatus and processes controllably generate medically useful micro or nano bubbles of medically desirable and controllably selectable size, size distribution, homogeneity and concentration (and/or other key bubble parameters) for patient infusion, and/or which may incorporate therapeutic or other agents for patient infusion and/or may be combined with therapeutic or other agents prior to infusion into patients. The bubble generation apparatus and processes controllably permit the adjustment and selection of key bubble parameters through bubble generation actuation and orientation techniques and through selection of bubble fluid compositions in order to facilitate medical research and/or to optimize treatment for imaging, therapy, sonoporation, inertial and non-inertial cavitation, and acoustic activation, among other medical uses. Disposable cartridges containing such bubbles are provided and may include means for patient infusion.
    Type: Grant
    Filed: May 5, 2008
    Date of Patent: September 4, 2012
    Assignee: Artenga, Inc.
    Inventors: James A. Keenan, Adrian Blenkinsop, Phillipe Genereux
  • Publication number: 20120029948
    Abstract: A method and system for determining a rate of insurance for management liability coverage which determines a base premium, a limit/retention factor, shared limit credits, and other rating considerations. The limit/retention factor, shared limit credits, and rating considerations are applied to the base premium to ascertain a resultant premium. Another aspect of the disclosure provides a method for determining a shared limit credit when insured clients purchase multiple insurance coverages in a single policy or package of policies and subject to common limit of liability.
    Type: Application
    Filed: July 22, 2011
    Publication date: February 2, 2012
    Applicant: American International Group
    Inventors: James Keenan Prendergast, James Kenneth Mangold
  • Publication number: 20120029949
    Abstract: A method and system for determining a rate of insurance for management liability coverage which determines a base premium, a limit/retention factor, shared limit credits, and other rating considerations. The limit/retention factor, shared limit credits, and rating considerations are applied to the base premium to ascertain a resultant premium. Another aspect of the disclosure provides a method for determining a shared limit credit when insured clients purchase multiple insurance coverages in a single policy or package of policies and subject to common limit of liability.
    Type: Application
    Filed: July 22, 2011
    Publication date: February 2, 2012
    Applicant: American International Group
    Inventors: James Keenan Prendergast, James Kenneth Mangold
  • Patent number: 8071508
    Abstract: Paste-extruded sulfonamide herbicide compositions having improved spray equipment clean-out properties are made by preparing a mixture comprising a sulfonamide herbicide free acid, at least about 50 equivalent % of an inorganic base relative to the sulfonamide herbicide free acid and sufficient water to form an extrudable past, extruding the mixture to form an extrudate, and drying the extrudate.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: December 6, 2011
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Josephe James Keenan, Luann Marshall Pugh, Robert Thomas Roche
  • Publication number: 20100228122
    Abstract: Method and medical devices for generating and stabilizing micro- or nano-bubbles, and systems and methods for therapeutic applications using the bubbles, are provided. The micro-bubbles may be used to enhance therapeutic benefits such as ultrasound-guided precision drug delivery and real-time verification, acoustic activation of large tumour masses, enhanced acoustic activation through longer retention of therapeutic agents at the point of interest, enhancement of high intensity focused ultrasound treatments, light activation of photodynamic drugs at a depth within a patient using extracorporeal light sources, probes, or sonoluminescence, and initiation of time reversal acoustics focused ultrasound to permit highly localized treatment.
    Type: Application
    Filed: January 7, 2010
    Publication date: September 9, 2010
    Applicant: ARTENGA INC.
    Inventors: James Keenan, Junjie Gu, Philippe Joel Genereux, Adrian T. Blenkinsop, David H. Gerwing, Sebastien Roy Fournier, Sarah Katherine Dobbin
  • Publication number: 20090117168
    Abstract: An implantable device for attracting diseased cells or foreign substances circulating within bodily fluid channels is disclosed. The device comprises a frame, an attachment means for maintaining the frame in a localized position in a body vessel, and at least one attractant on the frame, where the attractant is capable of attracting a diseased cell or a foreign substance. The device may also include a therapeutic agent The device may be used for diagnosis, disease containment or treatment. The device may also be used for attracting and localized treatment of diseased cells and foreign substances.
    Type: Application
    Filed: November 9, 2004
    Publication date: May 7, 2009
    Applicant: H.E.F.
    Inventor: James Keenan
  • Publication number: 20080319377
    Abstract: A method and medical device for generating transient bubbles is provided. Fluid is delivered under pressure through bubble generating means and thereby transient bubbles are generated. The bubbles are micro or nano sized. An ultrasonic source may be used to further vibrate the bubble generating means so as to adjust the size and size consistency of the bubbles. Infusion means may also be provided for infusing the bubbles in a patient. A therapeutic agent, in the form of or delivered in combination with, bubbles may be injected at the point of interest. An ultrasound pulse may additionally be provided to activate bubbles to enhance drug transport through tissues and across cell membranes. The device provides a means to locally generate transient bubbles, to facilitate acoustical activation of therapeutic agents, and the acoustic activation of bubbles infused within therapeutic agents, in order to enhance treatment efficacy.
    Type: Application
    Filed: May 4, 2005
    Publication date: December 25, 2008
    Inventor: James Keenan
  • Patent number: 7449589
    Abstract: A process for separating (?)-?9-trans-tetrahydrocannabinol from a mixture of cannabinoids is disclosed. The process comprises at least one chromatographic step wherein a mobile phase passes trough a stationary phase. The stationary phase comprises a derivatised polysaccharide and the mobile phase comprises carbon dioxide.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: November 11, 2008
    Assignee: Johnson Matthey Public Limited Company
    Inventors: Fiona Obrock Geiser, John James Keenan, Ronald Rossi, Albert Sanchez, John Michael Whelan
  • Publication number: 20080269668
    Abstract: Medical apparatus and processes controllably generate medically useful micro or nano bubbles of medically desirable and controllably selectable size, size distribution, homogeneity and concentration (and/or other key bubble parameters) for patient infusion, and/or which may incorporate therapeutic or other agents for patient infusion and/or may be combined with therapeutic or other agents prior to infusion into patients. The bubble generation apparatus and processes controllably permit the adjustment and selection of key bubble parameters through bubble generation actuation and orientation techniques and through selection of bubble fluid compositions in order to facilitate medical research and/or to optimize treatment for imaging, therapy, sonoporation, inertial and non-inertial cavitation, and acoustic activation, among other medical uses. Disposable cartridges containing such bubbles are provided and may include means for patient infusion.
    Type: Application
    Filed: May 5, 2008
    Publication date: October 30, 2008
    Inventors: James A. Keenan, Adrian Blenkinsop, Phillipe Genereux
  • Publication number: 20080126139
    Abstract: A method and system for determining a rate of insurance for management liability coverage which determines a base premium, a limit/retention factor, shared limit credits, and other rating considerations. The limit/retention factor, shared limit credits, and rating considerations are applied to the base premium to ascertain a resultant premium. Another aspect of the disclosure provides a method for determining a shared limit credit when insured clients purchase multiple insurance coverages in a single policy or package of policies and subject to common limit of liability.
    Type: Application
    Filed: November 21, 2007
    Publication date: May 29, 2008
    Applicant: American International Group, Inc.
    Inventors: James Keenan Prendergast, James Kenneth Mangold
  • Publication number: 20070197954
    Abstract: A medical device having enhanced ultrasonic visibility is provided. The device permits localized drug delivery, probe positioning, fluid drainage, biopsy, or ultrasound pulse delivery, through the real-time ultrasound monitoring of the needle tip position within a patient. The device permits controlled dispersion of a drug into solid tissue, the lodging of particles into solid tissue, and drug delivery into specific blood vessels. As a needle is inserted, a fluid that contrasts echogenically with the organ environment is injected into the patient. The fluid travels a brief distance before being slowed and stopped by the patient's tissue and this fluid flow will be detectable by ultrasound. The needle position during insertion will be monitored using ultrasound until it is at the desired point of action.
    Type: Application
    Filed: February 10, 2004
    Publication date: August 23, 2007
    Inventor: James Keenan
  • Publication number: 20070053162
    Abstract: One embodiment of an cabinet according to the present invention comprises an inner cabinet having a plurality of inner walls that form an enclosure. A phase change material covers at least some of the plurality of inner walls. An outer cabinet is positioned around the inner cabinet and comprises a plurality of outer walls arranged such that there is a space between the inner and outer walls. A mechanism is included for drawing air from outside of the outer cabinet into the space between the inner and outer walls. The phase-change material is arranged to melt when exposed to heat energy to reduce heat transfer into the enclosure. The enclosure is particularly adapted for holding heat sensitive devices such as batteries with the cabinet controlling heat transfer during cyclic heat exposure.
    Type: Application
    Filed: November 3, 2006
    Publication date: March 8, 2007
    Inventors: James Keenan, Richard Sevier
  • Publication number: 20050258929
    Abstract: Electric apparatus having distinct electric terminals has an input power terminal of electrically insulating material, including a base of electric insulating material having a first electric terminal base portion and a second electric base portion spaced from that first electric base portion, and a barrier wall of insulating material on that base acting as an isolator between the first and second electric terminals on these base portions, and preferably also as a standoff for a protective cover. A plurality of electric fuse holders in that or other electric apparatus may be mounted in mutually spaced relationship, and a heat sink including a frame around that plurality of mutually spaced electric fuse holders is in heat-transfer relationship with these electric fuse holders, and includes a cross-piece between each adjacent pair of the mutually spaced electric fuse holders.
    Type: Application
    Filed: October 1, 2003
    Publication date: November 24, 2005
    Inventors: Jeremiah Reyes, Richard Sevier, James Keenan, Jerry Rawlins, Paul Andreasen, Richard Bowers